Skip to main content
Log in

Nonattendance in the Stockholm mammography screening trial: Relative Mortality and reasons for nonattendance

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

The first objective of this study was to analyze the survival rate in a group of 69 breast cancers detected among nonattenders in a randomized mammographic screening trial in relation to 142 clinically detected cancers in a nonscreened control population. By analyzing the cancers of the nonattenders we identified two subgroups, one (A) had actively avoided mammography, had cancers in more advanced stages on diagnosis, and had significantly higher mortality from breast cancer than the control group (p = 0.003). The second subgroup (B) had mammography done outside the screening program. This subgroup had a nonsignificant, slightly better survival (p = 0.19) compared to the control group. Concerning stage the cancers in group B were similar to the cancers by the screening program.

The second objective was to analyze women's reasons for nonattendance in the screening program. We interviewed 200 randomly selected nonattenders; 33% stated that they never could imagine having mammography (definite nonattenders), 29.5% that they for various reasons had missed the mammography but could imagine having it next time (possible future attenders), and 32% had been examined outside the program. Reasons for nonattendance included disinterest, medical problems, and fear of X-rays. From this interview investigation we believe that the subgroup of definite nonattenders (33%) is difficult to influence. The second subgroup classified as possible future attenders (29.5%) we believe can be influenced by more information and a new opportunity to receive mammography, i.e., a reminder letter. The third subgroup, those examined outside the screening program (32%) were aware of the benefit of mammography, taking action on their own. Concerning these women's health this seems acceptable; screening outside the program seemed equivalent to that inside the program concerning stage and mortality in breast cancer as shown in the first part of the study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Day N, Williams D, Khaw K: Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer 59: 954–958, 1989

    Google Scholar 

  2. Tabár L, Fagerberg C, Duffy S, Day N: Recent results from the Swedish two-county trials of mammographic screening for breast cancer. J Epidem Comm Hlth 43: 107–114, 1989

    Google Scholar 

  3. Andersson I, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, Ljungberg O, Ranstam J, Sigfusson B: Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. Br Med J 297: 943–948, 1988

    Google Scholar 

  4. Shapiro S, Strax P, Venet L: Periodic breast cancer screening in reducing mortality from breast cancer. JAMA 215: 1777–1785, 1971

    Google Scholar 

  5. Tabár L, Gad A: Screening for breast cancer: The Swedish trial. Radiology 138: 219–222, 1981

    Google Scholar 

  6. Frisell J, Glas U, Hellström L, Somell A: Randomized mammographic screening for breast cancer in Stockholm. Design, first rounds results, and comparisons. Breast Cancer Res Treat 8: 45–54, 1986

    Google Scholar 

  7. Palli D, Rosselli del Turco M, Buiatti E, Carli S, Ciatto S, Toscani L, Maltoni G: A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy). Int J Cancer 38: 501–504, 1986

    Google Scholar 

  8. Roberts M, Alexander F, Anderson T, Forrest A, Hepburn W, Huggins A, Kirkpatrick A, Lamb J, Lutz W, Muir B: The Edinburgh randomised trial of screening for breast cancer: Description of method. Br J Cancer 50: 1–6, 1984

    Google Scholar 

  9. U K Trial, Early Detection of Breast Cancer Group. Trial of early detection of breast cancer: description of method. Br J Cancer 44: 618–627, 1981

    Google Scholar 

  10. Verbeek A, Holland R, Sturmans F, Hendriks J, Mravunac M, Day N: Reduction of breast cancer mortality through mass screening with modern mammography. Lancet 2: 1222–1224, 1984

    Google Scholar 

  11. Lundgren B: Population screening for breast cancer by single view mammography in a geographic region in Sweden. J Natl Cancer Inst 62: 1373–1379, 1979

    Google Scholar 

  12. Frisell J, Eklund G, Hellström L, Lidbrink E, Rutqvist L-E, Somell A: Randomized study of mammographic screening - preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 18: 49–56, 1991

    Google Scholar 

  13. Frisell J, Eklund G, Hellström L, Glas U, Somell A: The Stockholm breast cancer screening trial - 5-year results and stage at discovery. Breast Cancer Res Treat 13: 79–87, 1989

    Google Scholar 

  14. Armitage P, Berry G: Statistical Methods in Medical Research (Blackwell Scientific Publications): 14.2: 422-428, 14.6: 429-433, 8.1: 214-222, 4.4: 106-109, 1987

  15. Donato F, Bollani A, Spiazzi R, Pasquale L, Monarca L, Lucini L, Nardi G: Factors associated with non-participation of women in a breast cancer screening programme in a town in northern Italy. Journal of Epidemiology and Community Health 45: 59–64, 1991

    Google Scholar 

  16. Rutledge D, Hartmann W, Kinman P, Winfield A: Exploration of factors affecting mammography behaviors. Preventive Medicine 17: 412–422, 1988

    Google Scholar 

  17. U.K. Trial, Early Detection of Breast Cancer Group: First results on mortality reduction in the UK trial of early detection of breast cancer. Lancet 2: 411–416, 1988

    Google Scholar 

  18. Tabár L, Fagerberg G, Gad A, Baldetorp L, Holmberg L, Gröntoft D, Ljungkvist U, Lundström B, Månsson I, Eklund G, Pettersson F, Day N: Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1: 829–832, 1985

    Google Scholar 

  19. Fink R, Shapiro S, Roeser R: Impacts of efforts to increase participation in repetetive screenings for early breast cancer detection. Amer J Public Health 62: 328–336, 1972

    Google Scholar 

  20. Hobbs P, Smith A, George WD, Sellwood RA: Acceptors and rejectors of an invitation to undergo breast screening compared with those who referred themselves. Journal of Epidemiology and Community Health 34: 19–22, 1980

    Google Scholar 

  21. Rimer BK, Kasper Keintz M, Kessler HB, Engstrom PF, Rosan JR: Why women resist screening mammography: patient related barriers. Radiology 172: 243–246, 1989

    Google Scholar 

  22. Lerman G, Rimer B, Trock B, Balshem A, Engstrom PF: Factors associated with repeated adherence to breast cancer screening. Prev Med 19: 279–290, 1990

    Google Scholar 

  23. Lerman C, Rimer BK, Engstrom PF: Cancer risk notification: psychosocial and ethical implications. Journal of Clinical Oncology 9: 1275–1282, 1991

    Google Scholar 

  24. Rosenstock IM: The health belief model and preventive health behaviour. Health Education Monographs 345-386, 1975

  25. Peeters PHM, Verbeek ALM, Hendriks J, van Bon M: Screening for breast cancer in Nijmegen. Report of 6 screening rounds. Int J Cancer 43: 226–230, 1989

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lidbrink, E., Frisell, J., Brandberg, Y. et al. Nonattendance in the Stockholm mammography screening trial: Relative Mortality and reasons for nonattendance. Breast Cancer Res Tr 35, 267–275 (1995). https://doi.org/10.1007/BF00665978

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00665978

Key words

Navigation